Evidence map›Paper›PMID 30690128›Full record

Trial reportOphthalmology2019

Three-Year Observation of Children 3 to 10 Years of Age with Untreated Intermittent Exotropia.

Pediatric Eye Disease Investigator Group, Writing Committee, Brian G Mohney, Susan A Cotter, Danielle L Chandler, Jonathan M Holmes, David K Wallace, Tomohiko Yamada, David B Petersen, Raymond T Kraker and 3 more

Registry-linked trialOpen access · greenAbstract readMulticenter StudyObservational StudyRandomized Controlled Trial
In one paragraph

Trial report in Ophthalmology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01032330 (A Randomized Clinical Trial of Observation Versus Occlusion Therapy for Intermittent Exotropia), which is not on this map. Cited by 31 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 2 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01032330 nacompletednot on this map

A Randomized Clinical Trial of Observation Versus Occlusion Therapy for Intermittent Exotropia

TypeinterventionalSponsorJaeb Center for Health ResearchRan2010 to 2015Enrolled611ConditionsExotropiaArmsocclusion treatment
3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 2 syntheses or guidelines pooled it, 59 citations in OpenAlex.

  1. Guideline
  2. Interventions for intermittent exotropia.The Cochrane database of systematic reviews · 2021
    Pooled it
  3. Trial
  4. Trial
  5. Three-year observation of children 12 to 35 months old with untreated intermittent exotropia.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2020
    Trial
  6. Review
  7. Binocular Vision Anomalies: An Update on Prevalence, Impact, Technological and Treatment Developments and Current Challenges.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2026
    Review
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Clinical characteristics of intermittent exotropia according to fusional control: findings from the Korean Intermittent Exotropia Study (KIEMS).Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Pediatric Eye Disease Investigator Group
Writing Committee
Brian G MohneyDepartment of Ophthalmology, Mayo Clinic, Rochester, Minnesota. Electronic address: Pedig@jaeb.org.
Susan A CotterSouthern California College of Optometry at Marshall B. Ketchum University, Fullerton, California.
Danielle L ChandlerJaeb Center for Health Research, Tampa, Florida.
Jonathan M HolmesDepartment of Ophthalmology, Mayo Clinic, Rochester, Minnesota.
David K WallaceDepartment of Ophthalmology, Indiana University, Indianapolis, Indiana.
Tomohiko YamadaDepartment of Ophthalmology, Mayo Clinic, Rochester, Minnesota.
David B PetersenRocky Mountain Eye Care Associates, Salt Lake City, Utah.
Raymond T KrakerJaeb Center for Health Research, Tampa, Florida.
Christie L MorseConcord Eye Center, Concord, New Hampshire.
B Michele MeliaJaeb Center for Health Research, Tampa, Florida.
Rui WuJaeb Center for Health Research, Tampa, Florida.
Jaeb Center for Health Research · USMayo Clinic · USEye Care Associates · USIndiana University – Purdue University Indianapolis · USMarshall B. Ketchum University · US

Funding

Pediatric Eye Disease Investigator Group Coordinating CenterU10EY011751 · NEI · JAEB CENTER FOR HEALTH RESEARCH, INC. · PI KRAKER, RAYMOND · 1997 to 2018
$75.2M
Pediatric Eye Disease Investigator Group NetworkUG1EY011751 · NEI · JAEB CENTER FOR HEALTH RESEARCH, INC. · PI Raymond Kraker, Stacy Pineles · 2019 to 2026
$53.7M
Pediatric Eye Disease Investigator Group: Chair's OfficeU10EY018810 · NEI · MAYO CLINIC ROCHESTER · PI HOLMES, JONATHAN M · 2009 to 2013
$3.5M
PEDIATRIC EYE DISEASE INVESTIGATOR GROUP: CHAIR'S OFFICEU10EY023198 · NEI · INDIANA UNIVERSITY INDIANAPOLIS · PI WALLACE, DAVID K · 2014 to 2018
$1.4M
NEI NIH HHS U10 EY011751NEI NIH HHS U10 EY018810NEI NIH HHS U10 EY023198NEI NIH HHS UG1 EY011751
6 · The paper itself

Abstract

purposeTo describe the course of intermittent exotropia (IXT) in children followed up without treatment for 3 years.

designObservation arm from randomized trial of short-term occlusion versus observation.

participantsOne hundred eighty-three children 3 to 10 years of age with previously untreated IXT and 400 seconds of arc (arcsec) or better near stereoacuity.

methodsParticipants were to receive no treatment unless deterioration criteria were met at a follow-up visit occurring at 3 months, 6 months, or 6-month intervals thereafter for 3 years.

main outcome measuresThe primary outcome was deterioration by 3 years, defined as meeting motor criterion (constant exotropia ≥10 prism diopters [Δ] at distance and near) or near stereoacuity criterion (≥2-octave decrease from best previous measure). For the primary analysis, participants also were considered to have deteriorated if treatment was prescribed without meeting either deterioration criterion.

resultsThe cumulative probability of protocol-specified deterioration by 3 years was 15% (95% confidence interval, 10%-22%), but that was likely an overestimate, partly because of misclassification. Among 25 deteriorations, 2 met motor deterioration, 11 met stereoacuity deterioration, and 12 started treatment without meeting either criteria (7 for social concern, 1 for diplopia, 4 for other reasons). Among the 132 participants who completed the 3-year visit and had not been treated during the study, only 1 (<1%) met motor or stereoacuity deterioration criteria at 3 years. Of the 4 participants completing the 3-year visit who met deterioration criteria previously and had not started treatment, none still met deterioration criteria. Between the baseline and 3-year examination for these 132 patients, improvement occurred in distance and near stereoacuity (mean improvement, 0.14 and 0.14 logarithm of arcsec; P ≤ 0.001 and P ≤ 0.001, respectively), distance exotropia control (mean improvement, 0.6 points; P ≤ 0.001), and distance exodeviation magnitude (mean improvement, 2.2 Δ; P = 0.002).

conclusionsAmong children 3 to 10 years of age with IXT for whom surgery was not considered to be the immediately necessary treatment, stereoacuity deterioration or progression to constant exotropia over 3 years was uncommon, and exotropia control, stereoacuity, and magnitude of deviation remained stable or improved slightly.

Indexed as

BandagesChildChild, PreschoolDepth PerceptionExotropiaFemaleFollow-Up StudiesHumansMaleSensory DeprivationTime FactorsVision TestsVisual Acuity

Identifiers

PMID30690128
PMCPMC6660425
OpenAlexW2912374030

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.